RESUMEN
This study aimed to evaluate the safety and efficacy of innovative retinoic acid (RA) eluting stents with bioabsorbable polymer. Sixty stents divided in ten groups were implanted in the iliac arteries of 30 rabbits. Two polymers ("A", poly (lactic-co-glycolic acid) and "B", polylactic acid), and three doses ("Low", "Medium" and "High") of RA (groups: AL, AM, AH, BL, BM, BH) were used on cobalt chromium stents (Rontis Corporation), one group of bare stent (C), one group (D) of Everolimus eluting stent (Xience-Pro, Abbot Vascular), and two groups of Rontis Everolimus eluting stents coated with polymer A (EA) and B (EB). Treated arteries were explanted after 4 weeks, processed by methyl methacrylate resin and evaluated by histopathology. None of the implanted stents was related with thrombus formation or extensive inflammation. Image analysis showed limited differences between groups regarding area stenosis (BH, D and EB groups had the lower values). Group BH had lower intimal mean thickness than AH (105.1 vs 75.3 µm, p = 0.024). Stents eluting RA, a non-cytotoxic drug, were not related with thrombus formation and had an acceptable degree of stenosis 4 weeks post implantation. RA dose and type of polymer may play role in the biocompatibility of the stents.
Asunto(s)
Stents Liberadores de Fármacos , Arteria Ilíaca , Animales , Constricción Patológica/patología , Everolimus , Arteria Ilíaca/patología , Arteria Ilíaca/cirugía , Polímeros , Conejos , Stents , Tretinoina/farmacologíaRESUMEN
Aims: Empagliflozin (EMPA) demonstrates cardioprotective effects on diabetic myocardium but its infarct-sparing effects in normoglycemia remain unspecified. We investigated the acute and chronic effect of EMPA on infarct size after ischemia-reperfusion (I/R) injury and the mechanisms of cardioprotection in nondiabetic mice. Results: Chronic oral administration of EMPA (6 weeks) reduced myocardial infarct size after 30 min/2 h I/R (26.5% ± 3.9% vs 45.8% ± 3.3% in the control group, p < 0.01). Body weight, blood pressure, glucose levels, and cardiac function remained unchanged between groups. Acute administration of EMPA 24 or 4 h before I/R did not affect infarct size. Chronic EMPA treatment led to a significant reduction of oxidative stress biomarkers. STAT-3 (signal transducer and activator of transcription 3) was activated by Y(705) phosphorylation at the 10th minute of R, but it remained unchanged at 2 h of R and in the acute administration protocols. Proteomic analysis was employed to investigate signaling intermediates and revealed that chronic EMPA treatment regulates several pathways at reperfusion, including oxidative stress and integrin-related proteins that were further evaluated. Superoxide dismutase and vascular endothelial growth factor were increased throughout reperfusion. EMPA pretreatment (24 h) increased the viability of human microvascular endothelial cells in normoxia and on 3 h hypoxia/1 h reoxygenation and reduced reactive oxygen species production. In EMPA-treated murine hearts, CD31-/VEGFR2-positive endothelial cells and the pSTAT-3(Y705) signal derived from endothelial cells were boosted at early reperfusion. Innovation: Chronic EMPA administration reduces infarct size in healthy mice via the STAT-3 pathway and increases the survival of endothelial cells. Conclusion: Chronic but not acute administration of EMPA reduces infarct size through STAT-3 activation independently of diabetes mellitus.
Asunto(s)
Compuestos de Bencidrilo/farmacología , Cardiotónicos/farmacología , Células Endoteliales/efectos de los fármacos , Glucósidos/farmacología , Microvasos/efectos de los fármacos , Infarto del Miocardio/tratamiento farmacológico , Factor de Transcripción STAT3/metabolismo , Administración Oral , Animales , Compuestos de Bencidrilo/administración & dosificación , Cardiotónicos/administración & dosificación , Hipoxia de la Célula/efectos de los fármacos , Glucósidos/administración & dosificación , Humanos , Masculino , Ratones , Ratones Endogámicos C57BL , Infarto del Miocardio/metabolismo , Oxidación-Reducción , Estrés Oxidativo/efectos de los fármacosRESUMEN
BACKGROUND: Arterial function is regulated by estrogen, but no consistent pattern of arterial mechanical remodeling in response to depleted estrogen levels is available. OBJECTIVE: To examine long-term effects of ovariectomy (OVX) on the mechanical properties, morphology, and histological structure of the carotid artery in middle-aged rats and a potentially protective effect of Sideritis euboea extract (SID), commonly consumed as "mountain tea". METHODS: 10-month-old female Wistar rats were allocated into control (sham-operated), OVX, OVX+SID, and OVX+MALT (maltodextrin; excipient used for dilution of SID) groups. They were sacrificed after 6 months and their carotid arteries were submitted to inflation/extension tests and to dimensional and histological evaluation. RESULTS: Remodeling in OVX rats was characterized by a decreased in situ axial extension ratio, along with increased opening angle, thickness, and area of the vessel wall and of its medial layer, but unchanged lumen diameter. Compositional changes involved increased elastin/collagen densities. Characterization by the "four-fiber" microstructure-motivated model revealed similar in situ biaxial response of carotid arteries in OVX and control rats. CONCLUSIONS: Carotid artery remodeling in OVX rats was largely consistent with hypertensive remodeling, despite the minor arterial pressure changes found, and was not altered by administration of SID, despite previous evidence of its osteo-protective effect.
Asunto(s)
Arterias Carótidas/efectos de los fármacos , Arterias Carótidas/fisiología , Fenómenos Mecánicos/efectos de los fármacos , Ovariectomía/efectos adversos , Extractos Vegetales/farmacología , Sideritis/química , Animales , Fenómenos Biomecánicos/efectos de los fármacos , Peso Corporal/efectos de los fármacos , Arterias Carótidas/anatomía & histología , Femenino , Hemodinámica/efectos de los fármacos , Tamaño de los Órganos/efectos de los fármacos , Extractos Vegetales/administración & dosificación , Ratas , Ratas Wistar , Útero/efectos de los fármacos , Útero/crecimiento & desarrolloRESUMEN
Empagliflozin (EMPA), a drug approved for type 2 diabetes management, reduced cardiovascular death but is unknown if it reduces myocardial infarction. We sought to investigate: (i) the effect of EMPA on myocardial function and infarct size after ischemia/reperfusion in mice fed with western diet (WD), (ii) the underlying signaling pathways, (iii) its effects on cell survival in rat embryonic-heart-derived cardiomyoblasts (H9C2) and endothelial cells (ECs). To facilitate the aforementioned aims, mice were initially randomized in Control and EMPA groups and were subjected to 30 min ischemia and 2 h reperfusion. EMPA reduced body weight, blood glucose levels, and mean arterial pressure. Cholesterol, triglyceride, and AGEs remained unchanged. Left ventricular fractional shortening was improved (43.97 ± 0.92 vs. 40.75 ± 0.61%) and infarct size reduced (33.2 ± 0.01 vs. 17.6 ± 0.02%). In a second series of experiments, mice were subjected to the above interventions up to the 10th min of reperfusion and myocardial biopsies were obtained for assessment of the signaling cascade. STAT3 was increased in parallel with reduced levels of malondialdehyde (MDA) and reduced expression of myocardial iNOS and interleukin-6. Cell viability and ATP content were increased in H9C2 and in ECs. While, STAT3 phosphorylation is known to bestow infarct sparing properties through interaction with mitochondria, we observed that EMPA did not directly alter the mitochondrial calcium retention capacity (CRC); therefore, its effect in reducing myocardial infarction is STAT3 dependent. In conclusion, EMPA improves myocardial function and reduces infarct size as well as improves redox regulation by decreasing iNOS expression and subsequently lipid peroxidation as shown by its surrogate marker MDA. The mechanisms of action implicate the activation of STAT3 anti-oxidant and anti-inflammatory properties.
RESUMEN
INTRODUCTION: Beta-blocking agents are widely used for the treatment of many cardiovascular diseases. The effect of these agents, however, on the aortic wall structure and function has not been well defined. The present study was undertaken to investigate the effect of therapy with propranolol on wall structure and aortic function in rats. METHODS: 20 healthy Wistar rats (350-400 g) were assigned to a control group (n=8), with rats receiving only water and food, and an experimental group (n=12), in which 100 mg/kg/day propranolol was administered in the drinking water. Three months after initiation of treatment, aortic pressures and aortic pulse wave velocity (PWV) were measured using high-fidelity Millar catheters. Extensive histopathologic studies were performed in the wall of the descending thoracic aorta. RESULTS: Systolic, mean, diastolic, and pulse pressure were significantly lower in the propranolol-treated rats compared to controls (p<0.05). For any given systolic, mean, and pulse pressure, PWV was greater in the propranolol-treated animals (p<0.05). The heart rate was lower and the response to isoproterenol infusion was less in the propranolol-treated animals. Smooth muscle content was decreased and collagen content was increased in the aortic wall of the propranolol-treated animals compared to controls. CONCLUSIONS: Long-term propranolol administration elicits an increase in PWV adjusted for aortic pressure. This may be related to accumulation of collagen in the aortic wall at the expense of smooth muscle cells. The aortic stiffening may explain some of the reported data, suggesting that the effect of ß-blockade therapy in patients with arterial hypertension may be inferior to other pharmacologic agents.
Asunto(s)
Antagonistas Adrenérgicos beta/administración & dosificación , Aorta Torácica/efectos de los fármacos , Enfermedades de la Aorta/inducido químicamente , Músculo Liso Vascular/efectos de los fármacos , Propranolol/administración & dosificación , Rigidez Vascular/efectos de los fármacos , Administración Oral , Animales , Aorta Torácica/patología , Aorta Torácica/fisiopatología , Enfermedades de la Aorta/patología , Enfermedades de la Aorta/fisiopatología , Presión Sanguínea/efectos de los fármacos , Modelos Animales de Enfermedad , Esquema de Medicación , Masculino , Músculo Liso Vascular/patología , Ratas , Ratas WistarRESUMEN
Numerous studies have provided evidence of diameter adaptation secondary to flow-overload, but with ambiguous findings vis à vis other morphological parameters and information on the biomechanical aspects of arterial adaptation is rather incomplete. We examined the time course of large-artery biomechanical adaptation elicited by long-term flow-overload in a porcine shunt model between the carotid artery and ipsilateral jugular vein. Post-shunting, the proximal artery flow was doubled and retained so until euthanasia (up to three months post-operatively), without pressure change. This hemodynamic stimulus induced lumen diameter enlargement, accommodated by elastin fragmentation and connective tissue accumulation, as witnessed by optical and confocal microscopy. Heterogeneous mass growth of the adventitia was observed at the expense of the media, associated with declining residual strains and opening angle at three months. The in vitro elastic properties of shunted arteries determined by inflation/extension testing were also modified, with the thickness-pressure curves shifted to larger thicknesses and the diameter-pressure curves shifted to larger diameters at physiologic pressures, resulting in normalization of intramural and shear stresses within fifteen and thirty days, respectively. We infer that the biomechanical adaptation in moderate flow-overload leads to normalization of intimal shear, without, however, restoring compliance and distensibility at mean in vivo pressure to control levels.
Asunto(s)
Arterias Carótidas/química , Arterias Carótidas/fisiología , Flujo Sanguíneo Regional , Adaptación Fisiológica , Animales , Derivación Arteriovenosa Quirúrgica , Fenómenos Biomecánicos , Arterias Carótidas/cirugía , Hemodinámica , Masculino , Estrés Mecánico , Porcinos , Factores de TiempoRESUMEN
BACKGROUND: Sympathetic innervation exerts marked effects on vascular smooth muscle cells, including a short-term homeostatic (vasoconstrictor) and a direct trophic action promoting differentiation. However, the role of sympathetic nervous system in long-term structural and functional modulation of the aortic wall is yet undefined. METHODS: Six Landrace pigs underwent bilateral thoracic sympathectomy from the stellate to T8 ganglion, whereas 10 pigs underwent sham operation. Animals were sacrificed 3 mo postoperatively. Histometrical examination was performed on specimens from the thoracic (TA) and abdominal aorta (AA) utilizing an image-processing system. A uniaxial tensile tester was utilized for biomechanical evaluation; parameters of extensibility, strength, and stiffness of aortic tissue were calculated. RESULTS: Structural aortic remodeling of sympathectomized animals was observed, including increased inner aortic diameter in TA (15.3 ± 0.4 versus 10.4 ± 0.2 mm, P < 0.001) and AA (6.7 ± 0.3 versus 5.3 ± 0.2 mm, P = 0.002), and increased wall thickness in TA (2.0 ± 0.1 versus 1.6 ± 0.1 mm, P < 0.001) but not AA. Microscopic image analysis revealed increased elastin (TA: 50.1 ± 1.1 versus 29.7% ± 0.6%, P < 0.001; AA: 20.4 ± 2.1 versus 16.3% ± 0.6%, P = 0.03) and collagen density (only in TA: 22.0 ± 0.9 versus 15.4% ± 0.5%, P < 0.001), and decreased smooth muscle density (TA: 27.6 ± 1.3 versus 54.9% ± 0.7%, P < 0.001; AA: 57.2 ± 1.5 versus 63.4% ± 0.8%, P < 0.001). Sophisticated biomechanical analysis demonstrated that following sympathectomy, TA was equally extensible but manifested augmented strength (1344 ± 73 versus 1071 ± 52 kPa, P = 0.004) and stiffness (6738 ± 478 versus 5026 ± 273 kPa, P = 0.003), in accordance with extracellular matrix protein accumulation in that region. Differences in the AA were non-significant. CONCLUSIONS: Chronic thoracic sympathetic denervation causes significant structural and biomechanical remodeling of the thoracic aorta. Possible clinical implications for patients undergoing thoracic sympathectomy or chronically treated with sympathetic blockers require further investigation.
Asunto(s)
Aorta Torácica/patología , Aorta Torácica/fisiopatología , Simpatectomía/métodos , Procedimientos Quirúrgicos Torácicos/métodos , Animales , Aorta Torácica/inervación , Fenómenos Biomecánicos , Colágeno/metabolismo , Elastina/metabolismo , Femenino , Modelos Animales , Músculo Liso Vascular/patología , PorcinosRESUMEN
INTRODUCTION: The mechanical properties of the aorta play an important role in arterial homeostasis and constitute a prognostic factor in cardiovascular disease. This study determined the time-course of mechanical changes of the thoracic aorta following prolonged beta (beta)-blocker treatment. METHODS: Sixty-six healthy male Wistar rats were randomized to 4 groups. Group A was divided into subgroups A1 (n=6), A2 (n=6), and A3 (n=6), with animals receiving only water. In groups B (n=16), C (n=16), and D (n=16), propranolol was added to the drinking water (100 mg/kg/day). Animals of groups A1 and B, A2 and C, and A3 and D were sacrificed after 1, 2, and 3 months. The effect of beta-blockade was assessed by heart rate changes in response to isoproterenol infusion. The thoracic aorta was excised and submitted to mechanical testing. Regression analysis was performed to evaluate the relationship between elastic modulus and stress for low (part I), physiologic (part II), and high (part III) stresses. RESULTS: Data from subgroups A1, A2, and A3 were pooled together and were used as a control. Differences were found in the regression parameters of parts II and III between the propranolol-treated groups and controls, indicating that the aorta was stiffer in propranolol-treated rats compared to controls at physiologic stresses, and at physiologic and high strains. Changes developed progressively with the duration of treatment. No differences were found in the regression parameters of part I, indicative of non-varying elastic modulus, i.e. stiffness, at low stresses and strains. CONCLUSIONS: Chronic blockade of beta-adrenergic receptors induces changes in the mechanical properties of the thoracic aorta. Aortic stiffening in response to beta-blocker treatment may be of great clinical significance.
Asunto(s)
Antagonistas Adrenérgicos beta/efectos adversos , Aorta Torácica/efectos de los fármacos , Aorta Torácica/fisiología , Propranolol/efectos adversos , Animales , Fenómenos Biomecánicos , Masculino , Ratas , Ratas Wistar , Factores de TiempoRESUMEN
This experimental study investigates the effects of hypothyroidism on the descending thoracic aorta. Hypothyroidism was induced in 20 male Wistar rats by administering 0.05% of 6-n propyl 2-thiouracil (PTU) in their drinking water for 8 weeks. Euthyroid rats were used as controls. Animals were sacrificed and longitudinal strips of the descending aorta were subjected to various preselected levels of stress in a uniaxial tensile-testing device. Analysis of stress-strain, elastic modulus-strain curves disclosed significant differences between groups, indicative of stiffer aortas in hypothyroid animals at the upper physiologic and higher levels of pressure. Remodeling of the aortic wall of hypothyroid animals revealed significant histological changes. The thoracic aorta of hypothyroid rats compared with that of euthyroid ones became stiffer at high strains, including the upper physiologic range, loosing part of its distensibility. Hypothyroidism was also associated with diameter enlargement and substantial lengthening of the aorta.
Asunto(s)
Aorta Torácica/patología , Aorta Torácica/fisiopatología , Hipotiroidismo/patología , Hipotiroidismo/fisiopatología , Animales , Fenómenos Biomecánicos , Elasticidad , Técnicas In Vitro , Masculino , Ratas , Ratas Wistar , Estrés Mecánico , Resistencia a la TracciónRESUMEN
Thyroid hormones decrease systemic vascular resistance by directly affecting vascular smooth muscle relaxation. There is limited literature about their effect on the mechanical performance of the aortic wall. Therefore, the authors determined the influence of hyperthyroidism on the mechanical properties and histomorphological structure of the descending thoracic aorta in rats. Severe hyperthyroidism was induced in 20 male Wistar rats by administering L-thyroxine (T(4)) in their drinking water for 8 weeks; age-matched normal euthyroid rats acted as controls. Animals were sacrificed, and the mechanical and histomorphometrical characteristics of the descending thoracic aorta were studied. The aortic wall of hyperthyroid rats was stiffer than that of euthyroid animals at the upper physiologic levels of stress or strain (p < 0.05) but less stiff at the lower physiologic and lower levels (p < 0.05). The aorta of hyperthyroid animals compared with that of euthyroid ones showed an increase of the internal and external diameters (p < 0.05), the media area (p < 0.05), the number of smooth muscle cell nuclei (p < 0.05), and the collagen density (p < 0.05) and a decrease in the elastin laminae thickness (p < 0.001) and elastin density (p < 0.001). In hyperthyroid rats, the aortic wall was stiffer at the upper physiologic and higher levels of stress and strain. These changes correlated with microstructural changes of the aortic wall. The coexistence of hyperthyroidism with disease states or clinical conditions that predispose to increased arterial pressure may be associated with increased arterial stiffness and have undesirable consequences on the mechanical performance of the thoracic aorta and hemodynamic homeostasis. These changes could lead to an increased risk for developing vascular complications.